Why is the brain so prone to inflammation?

by Sarah C.P. Williams,Columbia University Irving Medical CenterKeeping neuroinflammation in check. Normal neurons (top panel) produce a small amount of double-stranded DNA (green) that keeps in

Updated on: March 19,2024

Why is the brain so prone to inflammation?

by Sarah C.P. Williams,Columbia University Irving Medical CenterKeeping neuroinflammation in check. Normal neurons (top panel) produce a small amount of double-stranded DNA (green) that keeps in

Updated on:March 19,2024

First study of the microvessels connecting the human cranium and brain

by CENIEHMicrophoramine distribution in adult human skulls. Credit: Bruner and EisovaEmiliano Bruner, a paleoneurologist at the Centro Nacional de Investigación sobre la Evolución Humana (CENIEH), has

Updated on: March 19,2024

First study of the microvessels connecting the human cranium and brain

by CENIEHMicrophoramine distribution in adult human skulls. Credit: Bruner and EisovaEmiliano Bruner, a paleoneurologist at the Centro Nacional de Investigación sobre la Evolución Humana (CENIEH), has

Updated on:March 19,2024

Counting from left to right feels 'natural,' but new research shows our brains count faster from bottom to top

by Luke Greenacre, Adrian Dyer, Jair Garcia and Scarlett Howard,The ConversationTesting how participants show preferences for either horizontal or vertical mental number lines by indicating the

Updated on: February 18,2024

Counting from left to right feels 'natural,' but new research shows our brains count faster from bottom to top

by Luke Greenacre, Adrian Dyer, Jair Garcia and Scarlett Howard,The ConversationTesting how participants show preferences for either horizontal or vertical mental number lines by indicating the

Updated on:February 18,2024

Mapping the human brain's default mode network: Anatomical study suggests it has widespread influence

Updated on: March 02,2025

Mapping the human brain's default mode network: Anatomical study suggests it has widespread influence

Updated on:March 02,2025

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q

Updated on: April 25,2024

Dementia care in Australia 'fragmented, challenging to navigate and hard to access'

by Medical Journal of Australia (MJA)Credit: CC0 Public DomainAustralia "does not currently meet the human rights of people with dementia to timely and accessible health services of appropriate q

Updated on:April 25,2024

Study models how ketamine's molecular action leads to its effects on the brain

by Massachusetts Institute of TechnologyA spectrogram of brain rhythm frequencies over time predicted by the team's model. After a first, moderate dose of ketamine gamma brain rhythm power (w

Updated on: May 30,2024

Study models how ketamine's molecular action leads to its effects on the brain

by Massachusetts Institute of TechnologyA spectrogram of brain rhythm frequencies over time predicted by the team's model. After a first, moderate dose of ketamine gamma brain rhythm power (w

Updated on:May 30,2024

Global dementia cases set to triple by 2050 unless countries address risk factors

by LancetCredit: Pixabay/CC0 Public DomainThe number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 m

Updated on: May 13,2024

Global dementia cases set to triple by 2050 unless countries address risk factors

by LancetCredit: Pixabay/CC0 Public DomainThe number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 m

Updated on:May 13,2024

New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

FEBRUARY 26, 2024byWeizmann Institute of ScienceCredit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-023-00020-yWeizmann Institute scientists have discovered two small molecules

Updated on: March 25,2024

New drugs cross blood-brain barrier to slow progression and even reverse symptoms of Huntington's disease

FEBRUARY 26, 2024byWeizmann Institute of ScienceCredit:EMBO Molecular Medicine(2024). DOI: 10.1038/s44321-023-00020-yWeizmann Institute scientists have discovered two small molecules

Updated on:March 25,2024

GlyNAC supplementation found to improve cognitive decline and brain health in aging

by Homa Shalchi,Baylor College of MedicineStudy experimental details. GCLC and GCLM = catalytic and modifier subunits of glutamate cysteine ligase enzyme; GSS = glutathione synthetase enzyme; GL

Updated on: March 30,2024

GlyNAC supplementation found to improve cognitive decline and brain health in aging

by Homa Shalchi,Baylor College of MedicineStudy experimental details. GCLC and GCLM = catalytic and modifier subunits of glutamate cysteine ligase enzyme; GSS = glutathione synthetase enzyme; GL

Updated on:March 30,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on: November 07,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on:November 07,2024

Simple tool shows life expectancy after dementia diagnosis

by Karolinska InstitutetTables illustrate three-year survival probabilities for people with dementia diagnosed in primary care. Dark green indicates a low risk of death while dark purple indicate

Updated on: June 20,2024

Simple tool shows life expectancy after dementia diagnosis

by Karolinska InstitutetTables illustrate three-year survival probabilities for people with dementia diagnosed in primary care. Dark green indicates a low risk of death while dark purple indicate

Updated on:June 20,2024

Researchers find possible neuromarker for 'juvenile-onset' Batten disease

by Kelsie Smith Hayduk,University of Rochester Medical CenterMeanMMN amplitude for each SOA in TD and CLN3 disease groups. Each scatter plot, box plot, and violin plot column represents in

Updated on: January 09,2024

Researchers find possible neuromarker for 'juvenile-onset' Batten disease

by Kelsie Smith Hayduk,University of Rochester Medical CenterMeanMMN amplitude for each SOA in TD and CLN3 disease groups. Each scatter plot, box plot, and violin plot column represents in

Updated on:January 09,2024